Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 1, 2013, Pages 190-195

  Baker, Ryan ^a   Han, Gang ^b   Sarangkasiri, Siriporn ^b   Demarco, Marylou ^b   Turke, Carolyn ^b   Stevens, Craig W ^b   Dilling, Thomas J ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DOSIMETRIC PARAMETER; ISOCENTERS; LUNG VOLUME; MEAN LUNG DOSE; MULTI VARIABLES; MULTIVARIABLE ANALYSIS; PLANNING TARGET VOLUMES; RADIATION PNEUMONITIS; STEREOTACTIC BODY RADIATION THERAPY; TUMOR SIZE; TUMOR VOLUMES; VOLUME RATIO;

DOSIMETERS; DOSIMETRY; EPIDEMIOLOGY; FACTOR ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

BIOLOGICAL ORGANS;

ADULT; AGE; AGED; ARTICLE; CARCINOID; CHARLSON COMORBIDITY INDEX; DISEASE SEVERITY; DOSIMETRY; FEMALE; GENDER; HISTOGRAM; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OXYGEN THERAPY; PLANNING TARGET VOLUME; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SMOKING; STEREOTACTIC BODY RADIATION THERAPY; TOTAL LUNG CAPACITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK; SEX FACTORS; SMOKING; TUMOR BURDEN;

EID: 84871376581     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.03.041     Document Type: Article

References (13)

1. R.D. Timmerman An overview of hypofractionation and introduction to this issue of Seminars in Radiation Oncology Semin Radiat Oncol 18 2008 215 222
2. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
3. T. Atsuya, S. Naoko, and K. Etsuo Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm Int J Radiat Oncol Biol Phys 73 2009 442 448
4. G.R. Borst, M. Ishikawa, and J. Nijkamp Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy Radiother Oncol 91 2009 307 313
5. M. Bishawi, B. Kim, and W.H. Moore Pulmonary function testing after stereotactic body radiotherapy to the lung Int J Radiat Oncol Biol Phys 82 2012 e107 e110
6. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
7. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
8. A. Takeda, T. Ohashi, and E. Kunieda Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors Int J Radiat Oncol Biol Phys 77 2010 685 690
9. H. Yamashita, K. Nakagawa, and N. Nakamura Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors Radiat Oncol 2 2007 21
10. M. Guckenberger, K. Baier, and B. Polat Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy Radiother Oncol 97 2010 65 70
11. M.C. Stauder, O.K. Macdonald, and K.R. Olivier Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions Radiother Oncol 99 2011 166 171
12. K.L. Stephans, T. Djemil, and C.A. Reddy Comprehensive analysis of pulmonary function test (PFT) changes after sterotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients J Thorac Oncol 4 2009 838 844
13. R. Timmerman, L. Papiez, and R. McGarry Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955 (Pubitemid 37433596)